Interferon-τ: A potential treatment for inflammatory central nervous system disease

Interferon Therapy of Multiple Sclerosis

Volumn , Issue , 1997, Pages 479-498

  Soos, Jeanne M ^a   Schiffenbauer, Joel ^b   Johnson, Howard M ^b   Pontzer, Carol H ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004522201     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (64)

1. Bazer FW, Johnson HM. Type I conceptus interferons: maternal recognition of pregnancy signals and potential therapeutic agents. Am J Reprod Immunol 1991; 26:19-22.
2. Johnson HM, Bazer FW, Szente BE, Jarpe MA. How interferons fight disease. Sci Am 1994; 270(5):40-47.
3. Bazer FW, Johnson HM, Yamamoto JK. Effect of ovine trophoblast protein- 1 (oTP-1) on replication of feline (FIV) and human (HIV) immunodeficiency viruses (abstr). Biol Reprod 1989; 40(suppl):63.
4. Pontzer CH, Bazer FW, Johnson HM. Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protein-1. Cancer Res 1991; 51:5304-5307.
5. Soos JM, Johnson HM. Type I interferon inhibition of superantigen-induced stimulation: implications for the treatment of superantigen-associated disease. J IFN Cytokine Res 1995; 15:39-45.
6. Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 1990; 8:579-621.
7. Soos JM, Subramaniam PS, Hobeika AC, Schiffenbauer J, Johnson HM. The interferon pregnancy recognition hormone, interferon tau, blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity. J Immunol 1995; 155:2747-2753.
8. Martal J, Lacroix MC, Loudes C, Saunier M, Wintenberger-Torres C. Trophoblastin, an anti-luteolytic protein present in early pregnancy in sheep. J Reprod Fertil 1979; 56:63-73.
9. Godkin JD, Bazer FW, Moffatt J, Sessions F, Roberts RM. Purification and properties of a major, low molecular weight protein released by the trophoblast of sheep blastocysts at day 13-21. J Reprod Fertil 1982; 65: 141-150.
10. Vallet JL, Bazer FW, Ashworth CJ, Johnson HM, Pontzer CH. Development of a radioimmunoassay for ovine trophoblast protein-1, the antiluteolytic protein from the sheep conceptus. J Endocrinol 1988; 117:R5-R8.
11. Godkin JD, Bazer FW, Thatcher WW, Roberts RM. Proteins released by cultured day 15-16 conceptuses prolong luteal maintenance when introduced into the uterine lumen of cyclic ewes. J Reprod Fertil 1984; 71:57-64.
12. Vallet JL, Bazer FW, Fliss MFV, Thatcher WW. Effect of ovine conceptus secretory proteins and purified ovine trophoblast protein-1 on interoestrous interval and plasma concentrations of prostaglandin F2alpha and E and of 13,14-dihydro-15-keto prostaglandin F2alpha in cyclic ewes. J Reprod Fertil 1988; 84:493-504.
13. Flint APF, Sheldrick EL, McCann TJ, Jones DSC. Luteal oxytocin: characteristics and control of synchronous episodes of oxytocin and PGF2alpha secretion at luteolysis in ruminants. Domest Anim Endocrinol 1990; 7: 111-124.
14. Mirando MA, Ott TL, Harney JP, Bazer FW. Ovine trophoblast protein-one inhibits development of endometrial responsiveness to oxytocin in ewes. Biol Reprod 1990; 43:1070-1078.
15. Bartol FF, Roberts RM, Bazer FW, Lewis GS, Godkin JD, Thatcher WW. Characterization of proteins produced in vitro by peri-attachment bovine conceptuses. Biol Reprod 1985; 32:681-693.
16. Gnatek GG, Smith LD, Duby RT, Godkin JD. Maternal recognition of pregnancy in the goat: effects of conceptus removal on interestrus intervals and characterization of conceptus protein production during early pregnancy. Biol Reprod 1989; 41:655-664.
17. Roberts RM, Cross JC, Leaman DW. Interferons as hormones of pregnancy. Endocr Rev 1992; 13:432-452.
18. Imakawa K, Anthony RV, Kazemi M, Marotti KR, Polites HG, Roberts RM. Interferon-like sequence of ovine trophoblast protein secreted by embryonic trophectoderm. Nature 1987; 330:377-379.
19. Stewart HJ, McCann SHE, Northrop AJ, Lamming GE, Flint APF. Sheep antiluteolytic interferon: cDNA sequence and analysis of mRNA levels. J Mol Endocrinol 1989; 2:65.
20. Klemann SW, Imakawa K, Roberts RM. Sequence variability among ovine trophoblast interferon mRNA. Nucleic Acids Res 1990; 18:6724.
21. Charlier M, Hue D, Boisnard M, Martal J, Gaye P. Cloning and structural analysis of two distinct families of ovine interferon-alpha genes encoding functional class II and trophoblast (oTP-1) alpha-interferons. Mol Cell Endocrinol 1991; 76:161-171.
22. Jarpe MA, Johnson HM, Bazer FW, Ott TL, Curto EV, Rama Krishna N, Pontzer CH. Predicted structural motif of IFN tau. Protein Eng 1994; 7: 863-867.
23. Pontzer CH, Torres BA, Vallet JL, Bazer FW, Johnson HM. Antiviral activity of the pregnancy recognition hormone ovine trophoblast protein-1. Biochem Biophys Res Commun 1988; 152:801-807.
24. Mirando MA, Short EC, Geisert RD, Vallet JL, Bazer FW. Stimulation of 2,5-oligoadenylate synthetase activity in sheep endometrium during pregnancy, by intrauterine infusion of oTP-1, and by intramuscular administration of recombinant bovine interferon-alphal. J Reprod Fertil 1991; 93:599.
25. Pontzer CH, Yamamoto JK, Bazer FW, Johnson HM. Potent anti-FIV and anti-HIV effect of interferon tau. J Immunol. In press.
26. Skopets B, Li J, Thatcher WW, Roberts RM, Hansen PJ. Inhibition of lymphocyte proliferation by bovine trophoblast protein-1 (type I trophoblast interferon) and bovine interferon-alphal. Vet Immunol Immunopathol 1992; 34:81-96.
27. Cross JC, Roberts RM. Constitutive and trophoblast-specific expression of a class of bovine interferon genes. Proc Natl Acad Sci USA 1991; 88: 3817-3821.
28. Whaley AE, Reddy Meka CS, Hunt JS, Imakawa K. Identification and cellular localization of unique interferon mRNA from human placenta. J Biol Chem 1994; 269:10864-10868.
29. Hansen TR, Kazemi M, Keisler DH, Malathy PV, Imakawa K, Roberts RM. Complex binding of the embryonic interferon, ovine trophoblast protein-1, to endometrial receptors. J Interferon Res 1989; 9:215-225.
30. Stewart Hi, McCann SHE, Lamming GE, Flint APF. Evidence for a role for interferon in the maternal recognition of pregnancy. J Reprod Fertil 1989; 37(suppl): 127-138.
31. Pontzer CH, Ott TL, Bazer FW, Johnson HM. Structure/function studies with interferon tau: evidence for multiple active sites. J Interferon Res. 1994; 14:133-141.
32. Senda T, Shimazu T, Matsuda S, Kawano G, Shimizu H, Nakamura KT, Mitsui Y. Three dimensional crystal structure of recombinant murine interferon beta. EMBO J 1992; 11:3193-3201.
33. Degré M. Influence of exogenous interferon on the peripheral white blood cell count in mice. Int J Cancer 1974; 14:699-703.
34. Fent K, Zbinden G. Toxicity of interferon and interleukin. Trends Pharm Sci 1987; 8:100-105.
35. David M, Larner AC. Activation of transcription factors by interferon-alpha in a cell free system. Science 1992; 257:813-815.
36. Schindler C, Shuai K, Prezioso VR, Darnell JE Jr. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 1992; 257:809-813.
37. Valazquez L, Fellous M, Stark GR, Pellegrini S. A protein tyrosine kinase in the interferon a/p signaling pathway. Cell 1992; 70:313-322.
38. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen O. Signaling by the cytokine receptor family: JAKs and STATs. Trends Biol Sci 1994; 19:222-227.
39. 38a. Subramaniam PS, Khan SA, Pontzer CH, Johnson HM. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities. Proc Natl Acad Sci USA 1995; 92: 12270-12274.
40. Langford MP, Stanton GJ, Johnson HM. Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun 1978; 22: 62-68.
41. Carlsson R, Sjogren HO. Kinetics of IL-2 and interferon production, expression of IL-2 receptors, and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin. A. Cell Immunol 1985; 96:175-183.
42. Johnson HM, Magazine HI. Potent mitogenic activity of staphylococcal enterotoxin A requires induction of IL-2. Int Arch Allergy Appl Immunol 1988; 87:87-90.
43. Bergdoll MS. The staphylococcal enterotoxins: an update. In: Jelijaszewicz J, ed. The Staphylococci. New York: Gustav Fischer Verlag, 1985:247--254.
44. Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic shock syndrome Staphylococcus aureus isolates. Lancet 1981; 1:1071-1072.
45. Johnson HM, Russell JK, Pontzer CH. Staphylococcal enterotoxin superantigens FASEB J 1991; 5:2706-2712.
46. Janeway CA, Yagi J, Conrad PJ, Katz ME, Jones B, Vroegop S, Buxser S. T-cell responses to MIs and bacterial proteins that mimic its behavior. Immunol Rev 1989; 107:61-88.
47. White J, Herman A, Pullen AM, Kubo R, Kappler JW, Marrack P. The Vi3 specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989; 56:27-35.
48. Carlsson R, Fischer H, Sjogren HO. Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol 1988; 140:2484-2488.
49. Fleischer B, Schrezenmeier H. T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J Exp Med 1988; 176:1697-1707.
50. Panitch HS, Hirsch RL, Haley AS, Johnson KP. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987; 1:893-895.
51. Panitch HS, Hirsch RL, Schindler J, Johnson KP. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 1987; 37:1097-1102.
52. Powell MB, Mitchell D, Lederman J, Buckmeier J, Zamvil SS, Graham M, Ruddle N, Steinman L. Lymphotoxin and tumor necrosis factor alpha production by myelin basic protein specific T cell clones correlates with encephalolitogenicity. Int Immunol 1990; 2:539-544.
53. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988; 23:339-346.
54. Fritz RB, Chou CH, McFarlin DE. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J Immunol 1983; 130(3): 1024-1026.
55. Schiffenbauer J, Johnson HM, Butfiloski E, Wegrzyn L, Soos JM. Staphylococcal enterotoxins reactivate experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 1993; 90:8543-8546.
56. Brocke S, Gaur A, Piercy C, Gautam A, Gijbels K, Fathamn CG, Steinman S. Induction of relapsing paralysis in experimental allergic encephalomyelitis by bacterial superantigen. Nature 1993; 365:642-644.
57. Soos JM, Schiffenbauer J, Johnson HM. Treatment of PL/J mice with the superantigen, straphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis. J Neuroimmunol 1993; 43:39-44.
58. Kalman B, Lublin FD, Lattime E, Joseph J, Knobler RL. Effects of staphylococcal enterotoxin B on T cell receptor Vβ utilization and clinical manifestations of experimental allergic encephalomyelitis. J Neuroimmunol 1993; 45: 83-88.
59. Soos JM, Hobeika AC, Butfiloski EJ, Schiffenbauer J, Johnson HM. Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-Vβ8 specific superantigen. Proc Natl Acad Sci USA 1995; 92:6082-6086.
60. IFNβ Multiple Sclerosis Study Group. Interferon IFNβ-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo controlled trial. Neurology 1993; 43:655.
61. Weinstock-Guttman B, Ransohoff RM, Kinkel RP, Rudnick RA. The interferons: biological effects, mechanisms of action, and use in multiple sclerosis. Ann Neurol 1995; 37:7-15.
62. Abramsky O, Lubetzki-Korn I, Evron S, Brenner T. Suppressive effect of pregnancy on MS and EAE. Prog Clin Biol Res 1984; 146:399-406.
63. Birk K, Ford C, Smeltzer S, Ryan D, Miller R, Rudnick RA. The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch Neurol 1990; 47:738-742.
64. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995; 118:253-261.